Topic - Moderna

Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies. - Source: Wikipedia

Related Stories

A nurse administers a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Miss., Friday, Nov. 18, 2022. U.S. regulators on Tuesday, April 18, 2023, cleared another COVID-19 booster dose for older adults and people with weak immune systems so they can shore up protection this spring — while taking steps to make coronavirus vaccinations simpler for everyone else.(AP Photo/Rogelio V. Solis)

Extra spring COVID-19 booster cleared for certain Americans

By Lauran Neergaard - Associated Press

A sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Moderna shares slipped Tuesday, April 11, 2023, after the COVID-19 vaccine developer said its potential flu vaccine needs more study in a late-stage clinical trial. (AP Photo/Bill Sikes) **FILE**

Moderna, Merck say vaccine-drug combo shows promise against melanoma

By Tom Howell Jr. - The Washington Times

Moderna CEO and Director Stephane Bancel arrives to testify to the Senate HELP Committee on the price of COVID-19 vaccine, Wednesday, March 22, 2023, on Capitol Hill in Washington. (AP Photo/Jacquelyn Martin)

Moderna CEO defends COVID vaccine price hike, citing pivot to endemic phase

By Tom Howell Jr. - The Washington Times

A Jackson-Hinds Comprehensive Health Center nurse loads a syringe with a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Miss., Friday, Nov. 18, 2022. Moderna recently announced early evidence that its updated booster induced BQ.1.1-neutralizing antibodies. (AP Photo/Rogelio V. Solis)

Vaccine makers pick Senate fight over soaring prices; fall boosters cost up to $130

By Tom Howell Jr. and Haris Alic - The Washington Times

Syringes with vaccines are prepared at the L.A. Care and Blue Shield of California Promise Health Plans' Community Resource Center where they were offering members and the public free flu and COVID-19 vaccines Friday, Oct. 28, 2022, in Lynwood, Calif. The U.S. is poised to make COVID-19 vaccinations more like a yearly flu shot, a major shift in strategy despite a long list of questions about how to best protect against a still rapidly mutating virus.The Food and Drug Administration asked its scientific advisers Thursday, Jan. 26, 2023, to help lay the groundwork for switching to once-a-year boosters for most Americans -- and how and when to periodically update the shots’ recipe. (AP Photo/Mark J. Terrill)

FDA’s advisers back plan to simplify COVID-19 vaccinations

By Lauran Neergaard - Associated Press

Illustration on COVID-19 restrictions, courts and patents by Linas Garsys/The Washington Times

Next COVID-19 battle will be waged in court

By Gregory Dolin

In this Jan. 21, 2021, file photo a medical staff member prepares the Pfizer COVID-19 vaccine at Tudor Ranch in Mecca, Calif. With vaccination against COVID-19 in full swing, social platforms like Facebook, Instagram and Twitter say they’ve stepped up their fight against misinformation that aims to undermine trust in the vaccines. (AP Photo/Jae C. Hong, File)

‘Twitter Files’: Big Pharma pressured platform to censor COVID-19 vaccine debate

By Joseph Clark - The Washington Times

Republican Florida Governor Ron DeSantis speaks during a campaign rally, Nov. 7, 2022, in Hialeah, Fla. The long-rumored memoir by Gov. DeSantis is coming out next year. The HarperCollins imprint Broadside will release “The Courage to Be Free: Florida’s Blueprint for America’s Revival” on Feb. 28. The announcement, Wednesday, Nov. 30, 2022 comes in the wake of DeSantis’ decisive reelection victory and will likely add to speculation that he plans a run for the Republican presidential nomination in 2024. (AP Photo/Lynne Sladky)

DeSantis announces grand jury probe of COVID-19 shots

By Susan Ferrechio - The Washington Times

Deborah Sampson, left, a nurse at a University of Washington Medical Center clinic in Seattle, gives a Pfizer COVID-19 vaccine shot to a 20-month-old child, June 21, 2022, in Seattle. The U.S. on Thursday, Dec. 8, 2022 open doses of the updated COVID-19 vaccines for most children younger than age 5. The Food and Drug Administration's decision aims to better protect the littlest kids from severe COVID-19 at a time when children’s hospitals already are packed with tots suffering a variety of other respiratory illnesses, too. (AP Photo/Ted S. Warren, file)

FDA clears updated COVID-19 vaccines for kids under age 5

By Lauran Neergaard - Associated Press

A Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site Feb. 8, 2022. Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11, Monday, Sept. 26. Already 4.4 million Americans have received one of the updated boosters since they rolled out earlier this month for anyone 12 and older. (AP Photo/Rogelio V. Solis, File)

FDA clears updated COVID boosters for kids as young as 5

By Lauran Neergaard - Associated Press

A vial of Moderna COVID-19 vaccine rests on a table at an inoculation station next to Jackson State University in Jackson, Miss., on July 19, 2022. British health authorities have authorized an updated version of Moderna's coronavirus vaccine that aims to protect against the original virus and the omicron variant. (AP Photo/Rogelio V. Solis)

FDA works to ease supply constraints of new Moderna booster

By Tom Howell Jr. - The Washington Times

This August 2022 photo provided by Pfizer shows vials of the company's updated COVID-19 vaccine during production in Kalamazoo, Mich. U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain. The move on Wednesday, Aug. 13, 2022, by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. (Pfizer via AP)

CDC advisers weigh who needs updated COVID booster and when

By Lauran Neergaard - Associated Press

A Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site Tuesday, Feb. 8, 2022. In August 2022, Pfizer and Moderna both asked U.S. regulators to authorize modified versions of their booster vaccine — shots that are half the original recipe and half protection against BA.4 and BA.5, the newest subtypes of the coronavirus omicron variant. (AP Photo/Rogelio V. Solis, File)

Tweaked COVID boosters close but how much will they help?

By Lauran Neergaard - Associated Press

A vial of Moderna COVID-19 vaccine rests on a table at an inoculation station next to Jackson State University in Jackson, Miss., on July 19, 2022. British health authorities have authorized an updated version of Moderna's coronavirus vaccine that aims to protect against the original virus and the omicron variant. (AP Photo/Rogelio V. Solis)

U.K. is the first country to approve reformulated COVID-19 shots

By Tom Howell Jr. - The Washington Times

Nora Burlingame, 3, is given a Pfizer COVID-19 vaccine shot, Tuesday, June 21, 2022, at a University of Washington Medical Center clinic in Seattle. COVID-19 shots for children between six months and five years of age were given federal authorization over the weekend. (AP Photo/Ted S. Warren)

COVID shots for tots flop despite Biden’s push

By Susan Ferrechio - The Washington Times